{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:12:34Z","timestamp":1785265954813,"version":"3.55.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2021R1G1A1007886"],"award-info":[{"award-number":["2021R1G1A1007886"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Soonchunhyang University Research Fund","award":["2021"],"award-info":[{"award-number":["2021"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Drug-induced liver injury (DILI) is the most common cause of acute liver failure in the United States. Painkillers and fever antipyretics are the most common cause of DILI. Hepatic injury can be provoked by DILI as hepatocellular or cholestatic type.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 48-year-old woman presented jaundice accompanied by nausea and vomiting. The patient was an inactive hepatitis B carrier with low viral titer and was diagnosed renal cell carcinoma (RCC) with hepatic metastasis requiring pazopanib treatment. Prior to administration of pazopanib, tenofovir administration was started to prevent exacerbation of hepatitis B. The patient was referred to clinic of gastroenterology department due to sudden elevation of bilirubin after 5\u200aweeks of pazopanib treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Abdominal ultrasound and computed tomography showed non-specific finding other than metastatic nodule in the liver and liver cirrhosis. After then, the patient was performed liver biopsy, and the biopsy result was acute cholestatic hepatitis with centrilobular area necrosis and portal inflammation. Therefore, considering the clinical history and biopsy results, the patient was diagnosed as DILI due to pazopanib.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>After the biopsy, empirical steroid therapy was initiated and after 7\u200aweeks of pazopanib discontinuation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The total bilirubin level returned to normal from peak level of 24.61 to 1.52\u200amg\/dL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>In patients with renal cell carcinoma, pazopanib treatment requires clinical caution as it causes rare complications such as severe jaundice and acute cholestatic hepatitis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027731","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T17:03:44Z","timestamp":1637341424000},"page":"e27731","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Pazopanib-induced severe acute liver injury"],"prefix":"10.1097","volume":"100","author":[{"given":"Jin-Wook","family":"Choi","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7802-0381","authenticated-orcid":false,"given":"Jeong-Ju","family":"Yoo","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gyune","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MOG.0b013e3283383c7c","article-title":"Drug-induced liver injury: a clinical update","volume":"26","author":"Ghabril","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop","volume":"52","author":"Fontana","year":"2010","journal-title":"Hepatology"},{"key":"R3-20250504","first-page":"289","article-title":"Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer","volume":"6","author":"Davidson","year":"2014","journal-title":"Int J Womens Health"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1634\/theoncologist.2012-0055","article-title":"Concise drug review: pazopanib and axitinib","volume":"17","author":"van Geel","year":"2012","journal-title":"Oncologist"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1200\/JCO.2009.23.9764","article-title":"Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial","volume":"28","author":"Sternberg","year":"2010","journal-title":"J Clin Oncol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.ejca.2015.03.019","article-title":"Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: a systematic review and meta-analysis of clinical trials in advanced cancer patients","volume":"51","author":"Powles","year":"2015","journal-title":"Eur J Cancer"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3109\/0284186X.2013.782103","article-title":"Risk of liver toxicity with the angiogenesis inhibitor pazopanib in cancer patients","volume":"52","author":"Kapadia","year":"2013","journal-title":"Acta Oncol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1200\/JCO.2011.41.0332","article-title":"Severe pazopanib-induced hepatotoxicity: clinical and histologic course in two patients","volume":"30","author":"Klempner","year":"2012","journal-title":"J Clin Oncol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12328-020-01253-x","article-title":"Pazopanib-induced mixed liver injury in a patient with soft-tissue sarcoma, but without the UGT1A1\u221728 mutation: a case report","volume":"14","author":"Hayashi","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s13691-017-0288-8","article-title":"Case of pazopanib-induced thyrotoxicosis in a patient with metastatic renal cell carcinoma","volume":"6","author":"Kuribayashi","year":"2017","journal-title":"Int Cancer Conf J"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12885-018-3999-0","article-title":"A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report","volume":"18","author":"Verschoor","year":"2018","journal-title":"BMC Cancer"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/14740338.2016.1194824","article-title":"Drug-induced hepatotoxicity in cancer patients - implication for treatment","volume":"15","author":"Vincenzi","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"62.e2","DOI":"10.1016\/j.clgc.2019.09.013","article-title":"Pazopanib-induced liver toxicity in patients with metastatic renal cell carcinoma: effect of UGT1A1 polymorphism on pazopanib dose reduction, safety, and patient outcomes","volume":"18","author":"Henriksen","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1158\/1078-0432.CCR-15-2044","article-title":"HLA-B\u221757:01 confers susceptibility to pazopanib-associated liver injury in patients with cancer","volume":"22","author":"Xu","year":"2016","journal-title":"Clin Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:07:13Z","timestamp":1746335233000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027731"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":15,"journal-issue":{"issue":"46","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027731","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"assertion":[{"value":"2021-09-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}